# Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

> **NCT04861584** · PHASE2 · RECRUITING · sponsor: **Zhujiang Hospital** · enrollment: 41 (estimated)

## Conditions studied

- Urinary Bladder Cancer

## Interventions

- **DRUG:** Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin

## Key facts

- **NCT ID:** NCT04861584
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-03
- **Primary completion:** 2026-10-03
- **Final completion:** 2027-04-03
- **Target enrollment:** 41 (ESTIMATED)
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04861584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04861584, "Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04861584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*